Lanxess AG buy DirectorDealer_Intensive
Start price
13.05.17
/
50%
€65.35
Target price
13.11.17
€71.89
Performance (%)
3.48%
End price
13.11.17
€66.92
Summary
This prediction ended on 13.11.17 with a price of €66.92. With a performance of 3.48%, the BUY prediction by DirectorDealer_Intensive for Lanxess AG closed with a slight gain. DirectorDealer_Intensive has 50% into this predictionLanxess is a German specialty chemicals company that produces a wide range of chemical products and additives for industries such as automotive, construction, and electronics. With operations in over 33 countries, its product portfolio includes high-performance plastics, synthetic rubber, performance chemicals, and water treatment solutions. The company is listed on the Frankfurt Stock Exchange and has a secondary listing on the OTC markets in the US under the symbol LNXSF.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Lanxess AG | -29.213% | -29.213% | -58.514% | -68.721% |
| iShares Core DAX® | -6.016% | -4.595% | 1.284% | 48.459% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.401% | 85.254% |
| iShares Nikkei 225® | -7.156% | -2.215% | 27.886% | 50.351% |
| iShares S&P 500 | -0.257% | -0.841% | 10.254% | 58.647% |
Comments by DirectorDealer_Intensive for this prediction
In the thread Lanxess AG diskutieren
Director's Dealing: Kauf
Director's Dealing / Insider Kauf von Zachert, Matthias (Geschäftsführendes Organ)
- Handelstag: 12.05.17
- Volumen: 197670 €
- Meldender: Zachert, Matthias
Wir werten alle Insider Käufe aus. Gemeinsam mit der Universität Innsbruck wurde eine Handelsstrategie auf Basis des Intensive Tradings entwickelt. Mehr Informationen findest du im Profil von DirectorDealer_Intensive.
Director's Dealing / Insider Kauf von Hanagarth, Dr. Heike (Aufsichtsrat)
- Handelstag: 15.05.17
- Volumen: 50018 €
- Meldender: Hanagarth, Dr. Heike
Director's Dealing / Insider Kauf von Walthie, Theo H. (Aufsichtsrat)
- Handelstag: 24.05.17
- Volumen: 147062 €
- Meldender: Walthie, Theo H.
Director's Dealing / Insider Kauf von Rosen, Lawrence Alan (Aufsichtsrat)
- Handelstag: 26.05.17
- Volumen: 31471 €
- Meldender: Rosen, Lawrence Alan
(Laufzeit überschritten)